ViTToria Biotherapeutics Funding & Investors
Vittoria Biotherapeutics develops gene-edited cell therapies. they provide next-generation, paradigm-shifting T-cell therapeutics that address unmet medical needs. Senza5 Technology from viTToria improves the efficacy, safety, and utility of cell-based treatments in preclinical settings.
vittoriabio.comTotal Amount Raised: $25,000,000
ViTToria Biotherapeutics Funding Rounds
Series Unknown
$15,000,000
Series Unknown Investors
Valley Forge InvestmentBioAdvanceTellus BioVenturesNYBC VenturesThe Leukemia & Lymphoma Society's Therapy Acceleration ProgramAgent CapitalUniversity of Pennsylvania (Penn)Seed
$10,000,000
Seed Investors
Agent CapitalTellus BioVenturesSV Health InvestorsPenn Medicine Co-Investment Program
Funding info provided by Diffbot.